Markets

Global Markets News

Silexion’s CFO Discusses 2024 Milestones and The Company’s Innovative Approach to KRAS-Driven Cancers
Wall Street Wire

Silexion’s CFO Discusses 2024 Milestones and The Company’s Innovative Approach to KRAS-Driven Cancers

Silexion Therapeutics Corp. (NASDAQ: SLXN)* recently released its full-year 2024 financial results and business update, showcasing remarkable progress in its clinical and preclinical programs targeting KRAS-driven cancers. Following these developments, we spoke with the Chief Financial Officer Mirit Horenshtein Hadar about the company’s achievements and strategic direction.

Duke Robotics Strengthens European Presence with New Greek Leadership Appointment
Wall Street Wire

Duke Robotics Strengthens European Presence with New Greek Leadership Appointment

Duke Robotics Corp. has appointed Alexandra Papaconstantinou as Managing Director of its Greek subsidiary, marking another milestone in the company’s European expansion strategy. The appointment comes just weeks after the establishment of Duke Robotics Hellas, the company’s first European branch. Papaconstantinou brings extensive experience in industrial engineering and

The Israeli Startup Redefining In-Game Advertising
Wall Street Wire

The Israeli Startup Redefining In-Game Advertising

The global gaming industry, now valued at approximately $188 billion, has become a dominant form of entertainment, particularly among younger audiences. Yet, despite its rapid expansion, monetization models have struggled to keep pace. Many existing approaches rely on disruptive pop-ups, forced video ads, or costly in-game purchases—methods

MedTech Innovator Inspira Advances AI-Powered Blood Monitoring Technology as Clinical Results Near
Wall Street Wire

MedTech Innovator Inspira Advances AI-Powered Blood Monitoring Technology as Clinical Results Near

In a landscape where medical technology increasingly intersects with artificial intelligence, Inspira Technologies (NASDAQ: IINN*) has announced a significant advancement in its blood monitoring platform. The Israeli medical device company has integrated a new oxygenation indicator into its AI-powered HYLA blood sensor, potentially eliminating the need for repeated blood

Market Leaders: Silexion’s Ilan Hadar Discusses Preclinical Milestones in KRAS-Driven Cancer Treatment, Market Momentum and Financing
Wall Street Wire

Market Leaders: Silexion’s Ilan Hadar Discusses Preclinical Milestones in KRAS-Driven Cancer Treatment, Market Momentum and Financing

Silexion Therapeutics* (NASDAQ: SLXN) is making strides in oncology with its RNAi-based treatment, SIL-204, targeting KRAS-driven cancers. In an interview on Market Leaders, CEO Ilan Hadar discussed the company’s recent breakthroughs and market activity. During the interview, Hadar highlighted that SIL-204 has shown promising preclinical